Herrmann John A III

About Herrmann John A III

John A. Herrmann III is a seasoned legal executive in the biopharmaceutical sector, most closely associated with Novavax Inc., a U.S.-listed company on Nasdaq. According to Novavax SEC filings, he has served since June 2020 as Executive Vice President, Chief Legal Officer and Corporate Secretary. Prior to that promotion, he advanced through a series of increasingly senior legal roles at Novavax, including Senior Vice President, General Counsel and Corporate Secretary from 2014 to 2020, Vice President, General Counsel and Corporate Secretary from 2012 to 2014, and Executive Director, Legal Affairs and Corporate Secretary from 2010 to 2012. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1000694/000110465922054754/tm223592d3_def14a.htm?utm_source=openai)) His earlier career shows deep legal experience across life sciences and regulated businesses. Before joining Novavax, he served as General Counsel at Ore Pharmaceuticals, Deputy General Counsel at Gene Logic, Senior Counsel at Celera Genomics, and Senior Corporate Counsel in Baxter Healthcare’s Renal Division. That background points to broad expertise in corporate governance, compliance, transactional support, risk management, and legal oversight for growth-stage healthcare organizations. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1000694/000110465922054754/tm223592d3_def14a.htm?utm_source=openai)) At Novavax, Herrmann played a long-standing role during the company’s evolution from a clinical development organization into a more global and commercial biopharmaceutical enterprise. Company communications state that over more than 14 years, he helped guide Novavax through that transition. In a chief legal officer and corporate secretary capacity, his responsibilities are typically associated with board governance, regulatory disclosures, corporate compliance, and the legal infrastructure supporting major company initiatives. ([ir.novavax.com](https://ir.novavax.com/press-releases/2023-11-17-Novavax-Makes-Changes-to-Executive-Leadership-Team-to-Enhance-Focus-on-Delivery-of-Strategic-Priorities?asPDF=1&utm_source=openai)) Overall, his profile reflects a governance-focused executive with a long internal tenure at a public company and a steady progression into top leadership responsibility. His academic credentials include a J.D. from the University of Illinois and a Bachelor of Arts in Political Science and History from Brown University. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1000694/000110465922054754/tm223592d3_def14a.htm?utm_source=openai))